These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6157470

  • 21. Phase II trial of (m-AMSA) 4'-9-(acridinylamino)-methanesulfon-m-aniside in primary liver cancer.
    Cheng E, Lightdale C, Young C, Yagoda A, Fortner J, Golbey R.
    Am J Clin Oncol; 1983 Apr; 6(2):211-3. PubMed ID: 6299095
    [No Abstract] [Full Text] [Related]

  • 22. Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma.
    Dombernowsky P, Siegenthaler P, Somers R, Hansen HH.
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):71-4. PubMed ID: 6896306
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Identification of the principal biliary metabolite of 4'-(9-acridinylamino)methanesulfon-m-anisidide in rats.
    Shoemaker DD, Cysyk RL, Padmanabhan S, Bhat HB, Malspeis L.
    Drug Metab Dispos; 1982 Jan; 10(1):35-9. PubMed ID: 6124380
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
    Wilson WR, Whitmore GF.
    Radiat Res; 1981 Jul; 87(1):121-36. PubMed ID: 7019954
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia.
    Legha SS, Keating MJ, Zander AR, McCredie KB, Bodey GP, Freireich EJ.
    Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Temporary effects of AMSA (4'-(9-acridinylamino) methanesulfon-m-anisidide) chemotherapy on spermatogenesis.
    da Cunha MF, Meistrich ML, Haq MM, Gordon LA, Wyrobek AJ.
    Cancer; 1982 Jun 15; 49(12):2459-62. PubMed ID: 7074561
    [Abstract] [Full Text] [Related]

  • 37. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma.
    Tan CT, Hancock C, Steinherz PG, Steinherz LJ, Sorell M, Chan KW, Mondora A, Miller DR.
    Cancer Res; 1982 Apr 15; 42(4):1579-81. PubMed ID: 6895864
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Enhancement of viral growth by the antitumor drug 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA).
    Drake S, Furlong NB, Nelson JA.
    Biochem Pharmacol; 1983 Sep 01; 32(17):2615-8. PubMed ID: 6688528
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.